PANLAR: SpA Guidelines Worldwide: Why Do They Differ?

Moderator(s)

• 

  Daniel Fernández-Ávila, MD, PhD, MSc

  Pontificia Universidad Javeriana - Hospital Universitario San Ignacio
• CL

  Carlos Lozada, MD

  University of Miami Miller School of Medicine

Speaker(s)

• 

  Xenofon Baraliakos, MD

  Rheumazentrum Ruhrgebiet Herne
• 

  Atul Deodhar, MD

  Oregon Health & Science University
• 

  Fernando Andres Sommerfleck, MD

  Sanatorio Julio Mendez

During this session, the new PANLAR, ASAS-EULAR and ACR/SAA/SPARTAN recommendations for the treatment of axial spondyloarthritis (axSpA) will be summarized and discussed. Differences and similarities will be highlighted, and the reasons for the development of new guidelines when others are available will be discussed by faculty and participants.

Learning Objectives:

• Recognize and summarize the main issues in the PANLAR, ACR and EULAR recommendations for the treatment of axial spondyloarthritis
• Explain the reason behind the development of new guidelines
• Explain the reason why, even using similar methodologies, guidelines may differ

Presentations:

• 12:00 PM – 12:15 PM ET

  New PANLAR Recommendations for the Treatment of Axial Spondyloarthritis
  Fernando Andres Sommerfleck, MD – Sanatorio Julio Mendez
• 12:15 PM – 12:30 PM ET

  2019 ACR/SAA/SPARTAN Recommendations for the Treatment of Ankylosing Spondylitis & Nonradiographic Axial Spondyloarthritis
  Atul Deodhar, MD – Oregon Health & Science University
• 12:30 PM – 12:45 PM ET

  ASAS-EULAR Management Recommendations for Axial Spondyloarthritis
  Xenofon Baraliakos, MD – Rheumazentrum Ruhrgebiet Herne
• 12:45 PM – 1:00 PM ET

  Q&A and Final Remarks